Imipramine on ER+ve and Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Imipramine
Sponsor: The University of Texas Health Science Center at San Antonio